Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on X:
“While reviewing ASH2025 abstracts, it’s striking how many prospective studies on cellular therapies and BiTEs are coming from China its like a Chinese Tsunami.”
More posts featuring Al-Ola Abdallah.